|
ZmaxDrug - Zmax The trade name of the product as shown on the labeling.
Dosage -
FOR SUSPENSION, EXTENDED RELEASE; ORAL
Active Ingredient(s) -
Azithromycin
Strength -
EQ 2GM BASE/BOT
Applicant -
PFIZER GLOBAL
New Drug Application (NDA) Number -
050797
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jun 10, 2005
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Pfizer Global Research Development
Zmax
Azelex 20% Cream; Topical
Finacea 15% Gel; Topical Optivar 0.05% Solution/drops; Ophthalmic Astelin Eq 0.125mg Base/spray Spray, Metered; Nasal Zithromax Eq 250mg Base **federal Register Determination That Product Was Not Discontinued Or Withdrawn For Safety Or Efficacy Reasons** Capsule; Oral Zmax Eq 2gm Base/bot For Suspension, Extended Release; Oral Imuran 25mg Tablet; Oral Imuran 50mg Tablet; Oral Azathioprine Sodium Eq 100mg Base/vial Injectable; Injection Imuran Eq 100mg Base/vial Injectable; Injection NewDrugInformation |